Robotics in GU oncology: Current status, future directions
The breadth of applications will widen as the number of new platforms grows, according Joshua Calvert, MD, MPH.
Role and rationale for molecular testing in advanced prostate cancer
Advances in genomic testing will help determine lines of therapy in men with mCSPC and mCRPC, according to Raoul S. Concepcion, MD.
How new agents may address NMIBC treatment challenges
Systemic and intravesical therapies are changing the landscape of BCG-unresponsive disease, according to Matthew Galsky, MD.
